Jean-Marc Schiano de Collela

A Phase 1 Study of Plamotamab, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma: Recommended Dose Safety/Efficacy Update and Escalation Exposure-Response Analysis

P. Riedell, H. Tilly, Jitendra Kanodia, 2022, Blood.

Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma.

R. Bouabdallah, D. Blaise, M. Mohty, 2011, Hematology/oncology and stem cell therapy.

Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution

R. Bouabdallah, L. Xerri, B. Chetaille, 2013, Leukemia & lymphoma.